| A genome wide association study identifies common variants associated with lipid levels in the Chinese population. |
| A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. |
| A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing. |
| A genome-wide scan for common variants affecting the rate of age-related cognitive decline. |
| ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. |
| APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. |
| Are C-reactive protein associated genetic variants associated with serum levels and retinal markers of microvascular pathology in Asian populations from Singapore? |
| Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. |
| Examination of the current top candidate genes for AD in a genome-wide association study. |
| Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study. |
| Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. |
| Genome-wide analysis of genetic loci associated with Alzheimer disease. |
| Genome-wide association analysis of age-at-onset in Alzheimer's disease. |
| Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. |
| Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women. |
| Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. |
| Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. |
| Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. |
| Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. |
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. |
| Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. |
| Genome-wide association study of Alzheimer's disease with psychotic symptoms. |
| Genome-wide association study of Alzheimer's disease. |
| Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. |
| Genome-wide characterization of shared and distinct genetic components that influence blood lipid levels in ethnically diverse human populations. |
| Genome-wide scan of copy number variation in late-onset Alzheimer's disease. |
| Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. |
| GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. |
| Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. |
| Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. |
| Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. |
| Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. |
| Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. |
| SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. |
| The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. |